“…In the TSC, nine species were located, with emphasis on Eugenia uniflora L, which has a strong inhibitory potential for α-glucose and, consequently, is promising for the treatment of diseases associated with the enzyme (Antônio, 2016;da Silva et al, 2022;Frausin et al, 2014;Seraglio et al, 2018;Thomas et al, 2009). The Meliaceae family is distributed in tropical and subtropical regions, such as the Americas, western India, Southeast Asia, and southern China, with 50 genera and 1400 species (Thomas et al, 2009).In the TSC, 13 species of this family were identified, and the bioactive compounds were extracted from the seeds, which have anti-inflammatory, antimutagenicity, and antitumor effects, therefore being widely used by the pharmaceutical industry (Muellner-Riehl and Rojas-Andrés, 2021; Tan et al, 2021). In turn, the families Moraceae and Lauraceae have a variety of species with different applications.…”